Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer

Conclusions Patients with IBF < 18 months are at significantly higher risk of DM and death from prostate cancer. The IBF may be used to guide patients and physicians considering the initiation of salvage ADT. Furthermore, an IBF < 18 months could be used to select “high-risk” patients for clinical trials investigating novel salvage systemic therapy.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research